Treatment options for acute myeloid leukemia (AML) in seniors have remained stagnant for 40 years. We are participating in Beat AML, a research study focused on swift phenotyping and tailored therapies, with the ultimate goal of improving outcomes in this disease that otherwise becomes increasingly difficult to treat as patients age.
Robert Collins, M.D.
February 14, 2018
